📖 Gene Editing in Humans, a First for the FDA

MedEvidence! Truth Behind the Data

MedEvidence! Truth Behind the Data
📖 Gene Editing in Humans, a First for the FDA
Jan 04, 2024
Dr. Michael Koren

Send us a text

Discover the future of medical science as we unravel the complexities of two FDA-approved gene editing therapies aimed at curing sickle cell disease. Our expert guest joins us to shed light on these groundbreaking treatments that could potentially rewrite the lives of countless individuals born with this genetic condition each year. Tune in and learn how this medical marvel, employing a modified virus and the precision of CRISPR-Cas9 technology, not only promises a brighter future for patients but also challenges our ethical boundaries.

As we navigate the intricacies of these life-altering therapies, we confront the societal and ethical implications of gene editing. While correcting lethal genetic defects in sickle cell disease opens doors to new possibilities, it simultaneously sparks a debate over the potential for 'designer' genetics and the looming threat of healthcare inequality. Engage with us as we dissect the monumental impact of these treatments and ponder the equitable distribution of such advanced healthcare innovations, all while considering what it means for the future of humanity.

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.com

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!